The share price of Challenger Limited (ASX: CGF) – Australia’s leading annuities provider – has declined by almost 50 per cent in the past 12 months. While the firm is clearly out of favour, I believe its long-term prospects could be better than the market is currently pricing in.
Readers will surely be aware that conditions have been tough for this business of late, with sales of annuities coming under pressure. Here is how Challenger put it when they reported in recent days:
Here is how Challenger put it when they reported in recent days:
Readers will know that a core part of any investment we make is to map the relationship between the stock price of business and the implied expectations for the key value drivers of the business. Only when we know what is currently priced in can we make a determination over the extent to which these market-implied expectations are reasonable, or otherwise.
The chart below shows our estimates for the approximate market-implied trajectory of the ratio between: (i) retail annuities sold by Challenger each year; and (ii) the annual flows into the Australian post-retirement space, from the accumulation space. By “market-implied”, we mean the trajectory of this ratio being priced in to Challenger’s current stock price.
Market-implied expectations for Challenger’s share of post-retirement flows
Source: MGIM estimates
As you can see, the current stock price of Challenger is basically saying that annuities will capture a declining share of the flows moving into post-retirement each year, forever. And who knows? Maybe this will turn out to be true. But if annuities end up playing a more significant role in the portfolios of Australian retirees then, under this scenario, the current expectations being priced into the stock are far too conservative. Said another way, under the scenario, the stock is materially undervalued.
The Montgomery Global Funds and Montaka own shares in Challenger. This article was prepared 15 August with the information we have today, and our view may change. It does not constitute formal advice or professional investment advice. If you wish to trade Challenger you should seek financial advice.